Research map: Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer

Back to the article

Papers in this map

  1. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency · Dung Thi Le · 2015 · 9599 citations · Cited by this paper
  2. Validation of the important role and prognostic value of KIF14 in triple-negative breast cancer · 2025 · Related
  3. Comprehensive molecular characterization of human colon and rectal cancer · The Cancer Genome Atlas Network · 2012 · 8841 citations · Cited by this paper
  4. NCAPD2 promotes the progression of lung adenocarcinoma through an AKT/MDM2/E2F1 positive feedback loop · 2025 · Related
  5. Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases · Bryan T. MacDonald · 2009 · 5676 citations · Cited by this paper
  6. A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancer · 2026 · Related
  7. Wnt signalling in stem cells and cancer · Tannishtha Reya · 2005 · 3709 citations · Cited by this paper
  8. Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD · 2026 · Related
  9. Microsatellite Instability in Cancer of the Proximal Colon · Stephen N. Thibodeau · 1993 · 3152 citations · Cited by this paper
  10. Assessing progesterone receptor modulation in glioblastoma: from in vitro and animal model to a human pilot protocol · 2025 · Related
  11. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation · Jamil Antonio Momand · 1992 · 3151 citations · Cited by this paper
  12. Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma · 2026 · Related
  13. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer · Richard A. Fishel · 1993 · 2906 citations · Cited by this paper
  14. The dual role of leukotrienes in the tumor microenvironment: balancing pro-tumorigenic and anti-tumor immunity · 2026 · Related
  15. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study · Michael James Overman · 2017 · 2892 citations · Cited by this paper
  16. Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF9 · 2025 · Related
  17. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis · Gideon Steinbach · 2000 · 2538 citations · Cited by this paper
  18. Jujuboside A induces bladder cancer cell apoptosis by inhibiting ATP1A2-mediated mitochondrial energy metabolism regulation · 2026 · Related
  19. TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders · Joan Massagué · 2000 · 2385 citations · Cited by this paper
  20. Immunoprevention Strategies for Colorectal Cancer in Lynch Syndrome Carriers · 2024 · Related
  21. Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer · Christine M. Ribic · 2003 · 2178 citations · Cited by this paper
  22. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling · Shih-Min A. Huang · 2009 · 2109 citations · Cited by this paper
  23. Drugging the undruggable RAS: Mission Possible? · Adrienne D. Cox · 2014 · 2061 citations · Cited by this paper
  24. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer · Mario F. Fraga · 2005 · 1938 citations · Cited by this paper
  25. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis · Daniele V. F. Tauriello · 2018 · 1890 citations · Cited by this paper
  26. Mutation of a mutL Homolog in Hereditary Colon Cancer · Nickolas Papadopoulos · 1994 · 1853 citations · Cited by this paper
  27. Mutant p53 in Cancer: New Functions and Therapeutic Opportunities · Patricia A. J. Muller · 2014 · 1599 citations · Cited by this paper
  28. Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer · Nicholas C. Nicolaides · 1994 · 1553 citations · Cited by this paper
  29. The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints · Nicolas Jose Llosa · 2014 · 1509 citations · Cited by this paper
  30. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters · Serge Saxonov · 2006 · 1446 citations · Cited by this paper
  31. ERK signalling: a master regulator of cell behaviour, life and fate · Hugo Lavoie · 2020 · 1262 citations · Cited by this paper
  32. Acquired Resistance to KRAS G12C Inhibition in Cancer · Mark M. Awad · 2021 · 1244 citations · Cited by this paper
  33. The MAPK signalling pathways and colorectal cancer · Jing‐Yuan Fang · 2005 · 1201 citations · Cited by this paper
  34. KRAS mutation: from undruggable to druggable in cancer · Lamei Huang · 2021 · 1134 citations · Cited by this paper
  35. Histone Modifications and Cancer · James E. Audia · 2016 · 1100 citations · Cited by this paper
  36. EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib · Ryan Bruce Corcoran · 2012 · 1044 citations · Cited by this paper
  37. Targeting p53 pathways: mechanisms, structures and advances in therapy · Haolan Wang · 2023 · 998 citations · Cited by this paper
  38. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies · Md Entaz Bahar · 2023 · 873 citations · Cited by this paper
  39. Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies · Silvia Benvenuti · 2007 · 832 citations · Cited by this paper

Source: OpenAlex (CC0)